Stay updated on Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial page.

Latest updates to the Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check20 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe date has been updated from April 24, 2025, to May 4, 2025.SummaryDifference0.3%
- Check48 days agoChange DetectedThe page has been updated to reflect a new revision version (v2.15.2) and the status has changed from 'Results Submitted' to 'Results Posted'.SummaryDifference1%
- Check62 days agoChange DetectedThe web page has updated its version from v2.14.4 to v2.15.0, indicating a revision in the content. The phrase 'Here’s how you know' has been modified, suggesting a change in the presentation or explanation of information.SummaryDifference1.0%
- Check70 days agoChange DetectedThe page has updated its revision number from v2.14.3 to v2.14.4 and now indicates that results have been submitted, replacing the previous status of no results posted.SummaryDifference1%
Stay in the know with updates to Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial page.